Accelerating clinical research across Europe.
Our Mission
Oxurion (Euronext Brussels: OXUR) is a Belgian company building a leading group of clinical research organizations in Europe. By acquiring and integrating specialist CROs across the full clinical research value chain — from study design, regulatory affairs and clinical operations to data management, biostatistics, medical writing, pharmacovigilance, real-world evidence and market access — Oxurion creates an end-to-end platform supporting drug and device development from early phases to post-approval.
Our Commitment
We are committed to building a resilient, multi-company CRO platform that integrates clinical development, evidence generation and market access — supporting faster, smarter and higher-quality decision-making across the product lifecycle.
Building a European clinical data platform.
Oxurion is a Euronext Brussels-listed company focused on building a next-generation European platform dedicated to clinical data, biometrics and AI-driven clinical research services. Through a targeted buy-and-build strategy, we consolidate high-value CRO and clinical technology capabilities.
72% controlling stake in Axiodis CRO
A French specialist in clinical biometrics and data management — the cornerstone of the Oxurion buy-and-build platform.
Learn more about AxiodisExagis — next-gen eCRF & data system
Proprietary platform purpose-built for biometrics and clinical data management workflows.
Discover ExagisPatient files processed across 12+ European countries.
Active partners: academic, biotech & pharma.
Full clinical data expertise
Biometrics, data management, statistical analysis and regulatory-ready clinical data.
AI integration
Intelligent data validation and virtual patient technologies on the active roadmap.
Active acquisition pipeline
Targeting complementary CRO and clinical data businesses across Europe.
Hybrid CRO + software
Combining operational CRO services with proprietary software and AI capabilities.
Axiodis CRO
Axiodis is a French clinical research organization specialized in biometrics, clinical data management and biostatistics. Through its proprietary Exagis platform and regulatory expertise, Axiodis supports biotech, pharmaceutical, medtech and academic sponsors in the execution of complex clinical studies.
Oxurion's ambition is to build a leading European clinical data ecosystem combining technology, regulatory expertise and operational excellence to accelerate the development of next-generation therapies.
Investor relations.
All the resources a shareholder needs — real-time quotes, financial filings, governance and dedicated contacts.
